Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
José Baselga Research Fund Announces First-Ever Grant to Advance Prion Disease Research
The José Baselga Research Fund (JBRF), supported by Alexion, AstraZeneca Rare Disease, today announced the […]
Roche Announces Collaboration with Lilly to Enhance Early Diagnosis of Alzheimer's Disease
Roche announced today that it has entered into a collaboration with Eli Lilly and Company […]
GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease “Diagnostic Odyssey”
GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, fueled by […]
Fusion Pharmaceuticals Announces First Patient Dosed in Phase 1 Study of FPI-2059, a Targeted Alpha Therapy (TAT) for the Treatment of Solid Tumors Expressing NTSR1
Fusion Pharmaceuticals, a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, has […]
Lunit Meets MDR CE Requirements for 3D Breast Tomosynthesis AI Solution
Lunit, a leading global provider of AI-powered cancer solutions, today announced that its AI solution […]
Investigational Oral Osteoarthritis Drug APPA May Have a Promising Senotherapeutic Effect with Potential in Other Diseases of Ageing
New data presented at the 2023 Osteoarthritis Research Society International (OARSI) World Congress in Denver, […]
Incyte Announces Data from Phase 2b Study Evaluating Povorcitinib (INCB54707) in Patients with Extensive Nonsegmental Vitiligo
Incyte has announced new data from a Phase 2b clinical trial evaluating the safety and […]
Oral Investigational Medicine Deuruxolitinib Significantly Improved Scalp Hair Regrowth in Alopecia Areata
Concert Pharmaceuticals, a company recently acquired by Sun Pharmaceutical, has announced the presentation of data […]
China's First Personalized Neoantigen-Targeted Cancer Vaccine Receives NMPA's Clinical Trial Approval
According to the latest data released in the Clinical Trials Implied Approval section on the […]
Kuria Therapeutics Completes FDA Pre-IND Consultation for Topical Nrf2 Activator for Corneal Endothelial Disease
Kuria Therapeutics, a pharmaceutical company developing novel ophthalmic and dermal therapeutics, is pleased to announce […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more